433
Views
16
CrossRef citations to date
0
Altmetric
Connective tissue diseases and related disorders

Clinical features of dermatomyositis associated with anti-MDA5 antibodies by age

, , , , , , , , , , , , , , , , , , , , , , , , , & show all
Pages 177-185 | Received 06 Nov 2019, Accepted 02 Mar 2020, Published online: 30 Mar 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Satoshi Ito, Shunsuke Sakai, Yoichi Kurosawa, Daisuke Kobayashi, Ryo Okabayashi, Asami Abe, Hiroshi Otani, Kiyoshi Nakazono, Akira Murasawa, Ichiei Narita & Hajime Ishikawa. (2021) The long-term observation of patients with rheumatoid arthritis who achieved a biological disease-modifying antirheumatic drug-free condition with adalimumab. Modern Rheumatology 31:4, pages 919-923.
Read now

Articles from other publishers (15)

Huaiya Xie, Dingding Zhang, Yuanzhuo Wang, Yixin Shi, Yuan Yuan, Luo Wang, Junping Fan, Xinlun Tian & Jinglan Wang. (2023) Risk factors for mortality in patients with anti-MDA5 antibody-positive dermatomyositis: A meta-analysis and systematic review. Seminars in Arthritis and Rheumatism 62, pages 152231.
Crossref
Shivraj Padiyar, Aswin M. Nair, Bijesh Yadav, Prathyusha Manikuppam, Avanish Jha, Abhilasha Arvind Manwatkar & John Mathew. (2023) Clinical Characteristics, Therapeutics, and Treatment Outcomes of Adult Patients with Anti-Melanoma Differentiation-Associated gene 5 Dermatomyositis: A Single-Center Experience from South India. Indian Journal of Rheumatology 18:3, pages 205-211.
Crossref
Shuangjun He, Yuhong Zhou, Chenyu Fan, Jun Ma, Yi Chen, Wanlong Wu & Xingyu Zhang. (2023) Differences in sex- and age-associated mortality in patients with anti-MDA5-positive dermatomyositis. Modern Rheumatology 33:5, pages 975-981.
Crossref
Hongli Wang, Jiyang Lv, Juan He, Wenqi Wu, Yuchao Zhong, Siyang Cao, Yueming Cai & Qingwen Wang. (2023) The prevalence and effects of treatments of rapidly progressive interstitial lung disease of dermatomyositis/polymyositis adults: A systematic review and meta-analysis. Autoimmunity Reviews 22:8, pages 103335.
Crossref
Enrico Fuzzi, Mariele Gatto, Margherita Zen, Chiara Franco, Elisabetta Zanatta, Anna Ghirardello & Andrea Doria. (2022) Anti-MDA5 dermatomyositis: an update from bench to bedside. Current Opinion in Rheumatology 34:6, pages 365-373.
Crossref
Xianhua Gui, Wangzhong Li, Yanzhe Yu, Tingting Zhao, Ziyi Jin, Kaifang Meng, Rujia Wang, Shenyun Shi, Min Yu, Miao Ma, Lulu Chen, Wei Luan, Xiaoyan Xin, Yuying Qiu, Xiaohua Qiu, Yingwei Zhang, Min Cao, Mengshu Cao, Jinghong Dai, Hourong Cai, Mei Huang & Yonglong Xiao. (2022) Prediction model for the pretreatment evaluation of mortality risk in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with interstitial lung disease. Frontiers in Immunology 13.
Crossref
Koichi Yamaguchi, Takahito Nakajima, Aya Yamaguchi, Miki Itai, Yuji Onuki, Yuki Shin, Shogo Uno, Sohei Muto, Shunichi Kouno, Masakiyo Yatomi, Haruka Aoki-Saito, Kenichiro Hara, Yukie Endo, Sei-ichiro Motegi, Yoshinao Muro, Masao Nakasatomi, Toru Sakairi, Keiju Hiromura, Natsumi Katsumata, Hiromi Hirasawa, Yoshito Tsushima & Toshitaka Maeno. (2022) Quantitative CT analysis of interstitial pneumonia in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: a single center, retrospective study. Clinical Rheumatology 41:5, pages 1473-1481.
Crossref
Zhi-Ming Ouyang, Jian-Zi Lin, Ao-Juan Tang, Ze-Hong Yang, Li-Juan Yang, Xiu-Ning Wei, Qian-Hua Li, Jin-Jian Liang, Dong-Hui Zheng, Bing-Peng Guo, Gui Zhao, Qian Han, Lie Dai & Ying-Qian Mo. (2022) A Matrix Prediction Model for the 6-Month Mortality Risk in Patients With Anti-Melanoma Differentiation-Associated Protein-5-Positive Dermatomyositis. Frontiers in Medicine 9.
Crossref
Inge Kortekaas Krohn, Joeri L. Aerts, Karine Breckpot, Cleo Goyvaerts, Edward Knol, Femke Van Wijk & Jan Gutermuth. (2021) T‐cell subsets in the skin and their role in inflammatory skin disorders. Allergy 77:3, pages 827-842.
Crossref
Donia Chebbi, Mouna Snoussi, Chifa Damak, Mouna Guermazi, Hend Hachicha, Faten Frikha, Raida Ben Salah, Hatem Masmoudi, Sameh Marzouk & Zouhir Bahloul. (2021) Clinical and therapeutic features of myositis associated with anti-MDA5 antibodies: three new cases. Pneumologia 70:4, pages 46-52.
Crossref
Anaïs Nombel, Nicole Fabien & Frédéric Coutant. (2021) Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies. Frontiers in Immunology 12.
Crossref
Harumichi Suma, Yusuke Yoshida, Tomohiro Sugimoto, Yoshimi Matsuo, Sze–Ming Law, Ran Nakashima, Hiroki Kobayashi, Yohei Hosokawa, Michinori Ishitoku, Hiroki Kohno, Hirofumi Watanabe, Tadahiro Tokunaga, Sho Mokuda, Takaki Nojima, Shintaro Hirata & Eiji Sugiyama. (2021) The clinical characteristics and predictors of severe digital ischemia in patients with anti‐aminoacyl transfer RNA synthetase antibodies. The Journal of Dermatology 48:7, pages 1044-1051.
Crossref
Pankti Mehta, Pedro M. Machado & Latika Gupta. (2021) Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry. Rheumatology International 41:6, pages 1021-1036.
Crossref
Yuhui Li, Yimin Li, Jian Wu, Miao Miao, Xiaojuan Gao, Wenxin Cai, Miao Shao, Xuewu Zhang, Yan Xu, Lu Cong, Jing He & Xiaolin Sun. (2020) Predictors of Poor Outcome of Anti-MDA5-Associated Rapidly Progressive Interstitial Lung Disease in a Chinese Cohort with Dermatomyositis. Journal of Immunology Research 2020, pages 1-8.
Crossref
Xianhua Gui, Wang-Zhong Li, Yanzhe Yu, Tingting Zhao, Ziyi Jin, Kaifang Meng, Rujia Wang, Shenyun Shi, Min Yu, Miao Ma, Lulu Chen, Wei Luan, Xiaoyan Xin, Yuying Qiu, Xiaohua Qiu, Yingwei Zhang, Min Cao, Mengshu Cao, Jinghong Dai, Jinghong Dai, Mei Huang & Yonglong Xiao. (2022) A Prediction Tool to Help with Mortality Risk Evaluation for Patients with Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis with Interstitial Lung Disease. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.